<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04234854</url>
  </required_header>
  <id_info>
    <org_study_id>OPTIMA</org_study_id>
    <nct_id>NCT04234854</nct_id>
  </id_info>
  <brief_title>OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque Using the MicroNet Covered Stent</brief_title>
  <acronym>OPTIMA</acronym>
  <official_title>OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard™ Stent in Patients With Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John Paul II Hospital, Krakow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InspireMD</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>John Paul II Hospital, Krakow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multicentric, multispecialty, international, open-label, single arm study using
      per-protocol intravascular ultrasound [IVUS, 20MHz electronic phase-array transducer] to
      document the procedure result of an effective plaque exclusion from the vessel lumen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigator initiated, academic, single arm, open-label, non-randomized, prospective,
      multicenter, multispecialty trial of CGuard™ use in all-comer population of consecutive
      patients with carotid stenosis related cerebral symptoms (TIA, stroke, retinal TIA, retinal
      stroke) or signs of ipsilateral brain injury on MRI or CT imaging.

      The main objective of this observational study is to evaluate an incidence of residual plaque
      prolapse after carotid stenting using the study device.

      Study Rationale In conventional carotid stents, plaque prolapse (PP) on intravascular imaging
      had been determined to be strongly associated with new post-procedural diffusion-weighted
      magnetic resonance lesions on cerebral imaging and with increased ischaemic stroke incidence.
      A significant increase in PP susceptibility was observed with unstable carotid plaque,
      pointing to the limitations of conventional CAS in unstable carotid plaques, such as
      symptomatic and increased-spontaneous-symptoms-risk lesions.

      This is reflected in current guidelines that provide a higher recommendation class to
      surgical management (CEA) rather than CAS for symptomatic lesions.

      Circumstantial evidence indicates that the novel carotid stent covered with MicroNET (CGuard
      EPS) may be an optimal device for effective carotid plaque sequestration (that may be
      particularly relevant in high-risk plaques) - but no systematic study has been performed thus
      far.

      Because of the increasing evidence that not only clinical symptoms (that may be related to
      for instance the affection of dominant vs. non-dominant haemisphere) but also signs of
      ipisilateral cerebral infarct/s are a hallmark of high-risk plaque and are associated with
      adverse prognosis, and because that neurology increasingly uses the term &quot;symptomatic&quot; to
      refer to carotid stenosis associated with clinically silent ipisilateral cerebral infarct/s,
      the present study will enroll both patients with clinical symptoms of cerebral ischaemia in
      relation to carotid stenosis and those with (clinically silent) signs of ipsilateral injury
      such as ischemic focus/foci on CT or MRI/DW-MRI).

      As previously demonstrated, clinically significant/relevant PP is that depicted by IVUS (with
      angiography, on the one hand, being not sensitive enough and OCT, on the other, being
      possibly too sensitive).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2020</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from plaque prolapse</measure>
    <time_frame>During index procedure</time_frame>
    <description>Freedom from plaque prolapse defined as observation of plaque inside the stent lumen after completion of the CAS procedure by IVUS assessment (Kotsugi 2017).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>During index procedure</time_frame>
    <description>stent delivery and implantation in absence of an intra-procedural clinical major adverse event, with no more than 30% residual diameter stenosis by on-site QCA, and successful withdrawal of the stent delivery and neuroprotection system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVUS interrogation success</measure>
    <time_frame>During index procedure</time_frame>
    <description>IVUS interrogation with an effective IVUS probe removal in absence of any clinical complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endovascular lumen reconstruction</measure>
    <time_frame>During index procedure</time_frame>
    <description>Freedom from plaque prolapse plus minimal in-stent area &gt;50% ICA reference area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periprocedural MACCE</measure>
    <time_frame>Until discharge or up to 24 hours</time_frame>
    <description>Death, stroke, myocardial infarction until discharge or up to 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days MACCE</measure>
    <time_frame>30 days</time_frame>
    <description>Death, stroke, myocardial infarction until 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any periprocedural complications</measure>
    <time_frame>Until discharge or up to 24 hours</time_frame>
    <description>Any complications occurring until discharge or 24 hours whichever comes first</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ipsilateral stroke between 31 days and 12 months after the procedure</measure>
    <time_frame>Between 31 days and 12 months after the procedure</time_frame>
    <description>Ipsilateral stroke between 31 days and 12 months after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duplex UltraSound (DUS) at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Peak Systolic Velocity (PSV) and End Diastolic Velocity (EDV) recorded by Duplex Doppler at 30±5 days after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duplex UltraSound (DUS) at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Peak Systolic Velocity (PSV) and End Diastolic Velocity (EDV) recorded by Duplex Doppler at 12 months after the procedure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">111</enrollment>
  <condition>Carotid Artery Diseases</condition>
  <arm_group>
    <arm_group_label>Carotid Artery Stenting</arm_group_label>
    <description>Consecutive patients older than 18 yrs with symptomatic carotid artery stenosis qualified for endovascular revascularization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Intravascular Utrasound (IVUS) of Carotid Artery after implantation of CGuard stent</intervention_name>
    <description>IVUS will be performed after stent postdilatation to determine the incidence of plaque prolapse. Additionally optimizing stent expansion with IVUS is left at operator discretion.</description>
    <arm_group_label>Carotid Artery Stenting</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive clinically-symptomatic patients (ipsilateral cerebral or retinal stroke or TIA
        with the preceding 6 months) with atherosclerotic de novo carotid artery stenosis causing
        at least 50% lumen reduction by quantitative carotid catheter angiography (QCA) or carotid
        stenosis of at least 50% lumen reduction by QCA in relation to documented ipsilateral
        ischaemic brain lesions/infarct on CT or MRI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive patients with clinically symptomatic carotid stenosis , or carotid
             stenosis associated with ipisilateral cerebral ischemic infarct/s on CT or MRI/DWI
             imaging, referred and accepted by the study center for CAS as per local standard
             referral pathways and study center routine.

          -  Patient informed consent to participate.

          -  Patient accepts follow-up scheme and consents to follow-up visits.

        Exclusion Criteria:

          -  Lack of indication to carotid revascularization as per current ESC/ESVS Guidelines, or
             any clinical or angiographic or other contraindication to CAS (such as renal failure
             defined as creatinine level &gt; 2.5 mg/dL or eGFR &lt;20 ml/kg min, or incompatibility with
             DAPT).

          -  Surgery within the preceding 30 days or planned surgery within 30 days after CAS.

          -  Life expectancy &lt;1 year (eg. neoplastic disease).

          -  MI within 72h prior to CAS.

          -  Known coagulopathy.

          -  History of cerebral stroke with documented/known cause other than carotid disease.

          -  Atrial fibrillation or flutter.

          -  Any known cause for potential cerebral embolization different than carotid stenosis.

          -  History of intracranial bleeding.

          -  Any contraindications to as per IFU study device implantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Musialek, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Cardiac and Vascular Diseases, The John Paul II Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Piotr Musialek, Prof.</last_name>
    <phone>+48126142287</phone>
    <email>p.musialek@szpitaljp2.krakow.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiac and Vascular Diseases, The John Paul II Hospital</name>
      <address>
        <city>Kraków</city>
        <state>Maloplska</state>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Musialek, Prof</last_name>
      <phone>+48126142287</phone>
      <email>p.musialek@szpitaljp2.krakow.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Kotsugi M, Takayama K, Myouchin K, Wada T, Nakagawa I, Nakagawa H, Taoka T, Kurokawa S, Nakase H, Kichikawa K. Carotid Artery Stenting: Investigation of Plaque Protrusion Incidence and Prognosis. JACC Cardiovasc Interv. 2017 Apr 24;10(8):824-831. doi: 10.1016/j.jcin.2017.01.029.</citation>
    <PMID>28427600</PMID>
  </reference>
  <reference>
    <citation>Musialek P, Pieniazek P, Tracz W, Tekieli L, Przewlocki T, Kablak-Ziembicka A, Motyl R, Moczulski Z, Stepniewski J, Trystula M, Zajdel W, Roslawiecka A, Zmudka K, Podolec P. Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions. Med Sci Monit. 2012 Feb;18(2):MT7-18.</citation>
    <PMID>22293887</PMID>
  </reference>
  <reference>
    <citation>Clark DJ, Lessio S, O'Donoghue M, Schainfeld R, Rosenfield K. Safety and utility of intravascular ultrasound-guided carotid artery stenting. Catheter Cardiovasc Interv. 2004 Nov;63(3):355-62.</citation>
    <PMID>15505835</PMID>
  </reference>
  <reference>
    <citation>Bandyk DF, Armstrong PA. Use of intravascular ultrasound as a &quot;Quality Control&quot; technique during carotid stent-angioplasty: are there risks to its use? J Cardiovasc Surg (Torino). 2009 Dec;50(6):727-33.</citation>
    <PMID>19935603</PMID>
  </reference>
  <reference>
    <citation>Hitchner E, Zhou W. Utilization of Intravascular Ultrasound during Carotid Artery Stenting. Int J Angiol. 2015 Sep;24(3):185-8. doi: 10.1055/s-0035-1556081. Epub 2015 Jul 10.</citation>
    <PMID>26417186</PMID>
  </reference>
  <reference>
    <citation>Musialek P, Hopf-Jensen S. Commentary: Carotid Artery Revascularization for Stroke Prevention: A New Era. J Endovasc Ther. 2017 Feb;24(1):138-148. doi: 10.1177/1526602816671263. Epub 2016 Oct 13.</citation>
    <PMID>27733691</PMID>
  </reference>
  <reference>
    <citation>Schofer J, Musiałek P, Bijuklic K, Kolvenbach R, Trystula M, Siudak Z, Sievert H. A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv. 2015 Aug 17;8(9):1229-1234. doi: 10.1016/j.jcin.2015.04.016.</citation>
    <PMID>26292586</PMID>
  </reference>
  <reference>
    <citation>Musialek P, Mazurek A, Trystula M, Borratynska A, Lesniak-Sobelga A, Urbanczyk M, Banys RP, Brzychczy A, Zajdel W, Partyka L, Zmudka K, Podolec P. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention. 2016 Aug 5;12(5):e658-70. doi: 10.4244/EIJY16M05_02.</citation>
    <PMID>27180302</PMID>
  </reference>
  <reference>
    <citation>Ruffino MA, Faletti R, Fronda M, Gatti M, Bergamasco L, Gibello L, Varetto G, Righi D, Rispoli P, Fonio P. Early Embolization After Carotid Artery Stenting with Mesh-Covered Stent: Role of Diffusion-Weighted Magnetic Resonance Imaging as Pre-procedural Predictor and Discriminant Between Intra- and Post-procedural Events. Cardiovasc Intervent Radiol. 2019 Jun;42(6):812-819. doi: 10.1007/s00270-019-02173-1. Epub 2019 Feb 19.</citation>
    <PMID>30783778</PMID>
  </reference>
  <reference>
    <citation>Speziale F, Capoccia L, Sirignano P, Mansour W, Pranteda C, Casana R, Setacci C, Accrocca F, Alberti D, de Donato G, Ferri M, Gaggiano A, Galzerano G, Ippoliti A, Mangialardi N, Pratesi G, Ronchey S, Ruffino A, Siani A, Spinazzola A, Sponza M. Thirty-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard MicroNet-covered Embolic Prevention System in real-world multicentre clinical practice: the IRON-Guard study. EuroIntervention. 2018 Feb 20;13(14):1714-1720. doi: 10.4244/EIJ-D-17-00008.</citation>
    <PMID>28485278</PMID>
  </reference>
  <reference>
    <citation>Musiałek P, Grunwald IQ. How asymptomatic is &quot;asymptomatic&quot; carotid stenosis? Resolving fundamental confusion(s) - and confusions yet to be resolved. Pol Arch Intern Med. 2017 Nov 30;127(11):718-719. doi: 10.20452/pamw.4157. Epub 2017 Nov 30.</citation>
    <PMID>29192895</PMID>
  </reference>
  <reference>
    <citation>Stabile E, Sannino A, Schiattarella GG, Gargiulo G, Toscano E, Brevetti L, Scudiero F, Giugliano G, Perrino C, Trimarco B, Esposito G. Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. JACC Cardiovasc Interv. 2014 Oct;7(10):1177-83. doi: 10.1016/j.jcin.2014.05.019. Epub 2014 Sep 17. Review.</citation>
    <PMID>25240544</PMID>
  </reference>
  <reference>
    <citation>Wissgott C, Schmidt W, Brandt-Wunderlich C, Behrens P, Andresen R. Clinical Results and Mechanical Properties of the Carotid CGUARD Double-Layered Embolic Prevention Stent. J Endovasc Ther. 2017 Feb;24(1):130-137. doi: 10.1177/1526602816671134. Epub 2016 Oct 13.</citation>
    <PMID>27733689</PMID>
  </reference>
  <reference>
    <citation>Stabile E, de Donato G, Musialek P, De Loose K, Nerla R, Sirignano P, Chianese S, Mazurek A, Tesorio T, Bosiers M, Setacci C, Speziale F, Micari A, Esposito G. Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery: Results of a Patient-Based Meta-Analysis of 4 Clinical Studies. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2405-2411. doi: 10.1016/j.jcin.2018.06.047.</citation>
    <PMID>30522670</PMID>
  </reference>
  <reference>
    <citation>Casana R, Tolva V, Odero A Jr, Malloggi C, Paolucci A, Triulzi F, Silani V. Safety and Efficacy of the New Micromesh-Covered Stent CGuard in Patients Undergoing Carotid Artery Stenting: Early Experience From a Single Centre. Eur J Vasc Endovasc Surg. 2017 Dec;54(6):681-687. doi: 10.1016/j.ejvs.2017.09.015. Epub 2017 Oct 28.</citation>
    <PMID>29089282</PMID>
  </reference>
  <reference>
    <citation>Umemoto T, de Donato G, Pacchioni A, Reimers B, Ferrante G, Isobe M, Setacci C. Optical coherence tomography assessment of newgeneration mesh-covered stents after carotid stenting. EuroIntervention. 2017 Dec 20;13(11):1347-1354. doi: 10.4244/EIJ-D-16-00866.</citation>
    <PMID>28760722</PMID>
  </reference>
  <reference>
    <citation>de Donato G, Setacci F, Sirignano P, Galzerano G, Cappelli A, Setacci C. Optical coherence tomography after carotid stenting: rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013 Jun;45(6):579-87. doi: 10.1016/j.ejvs.2013.03.005. Epub 2013 Apr 10.</citation>
    <PMID>23582886</PMID>
  </reference>
  <reference>
    <citation>Umemoto T, Pacchioni A, Nikas D, Reimers B. Recent developments of imaging modalities of carotid artery stenting. J Cardiovasc Surg (Torino). 2017 Feb;58(1):25-34. doi: 10.23736/S0021-9509.16.09813-X. Epub 2016 Dec 6. Review.</citation>
    <PMID>27922253</PMID>
  </reference>
  <reference>
    <citation>de Donato G, Setacci C, Umemoto T, Reimers B. Commentary: Inside of the Interaction Between the Plaque and the Stent: Optical Coherence Tomography During Carotid Artery Stenting. J Endovasc Ther. 2015 Dec;22(6):950-1. doi: 10.1177/1526602815611885.</citation>
    <PMID>26586654</PMID>
  </reference>
  <reference>
    <citation>Musialek P, Stabile E. Residual plaque prolapse with novel dual-layer carotid stents: is it mesh-covered or not? EuroIntervention. 2017 Dec 20;13(11):1266-1268. doi: 10.4244/EIJV13I11A199.</citation>
    <PMID>29260718</PMID>
  </reference>
  <reference>
    <citation>Pacchioni A, Ribichini F, Reimers B. Stent Type and Risk of Late Cerebral Events After Carotid Artery Stenting. J Am Coll Cardiol. 2015 Jul 28;66(4):490. doi: 10.1016/j.jacc.2015.04.074.</citation>
    <PMID>26205606</PMID>
  </reference>
  <reference>
    <citation>Secco GG, Cremonesi A, Amor M, Pistis G, Reimers B, Castriota F. Optical coherence tomography during carotid artery stenting: A new niche application? Int J Cardiol. 2015;187:372-3. doi: 10.1016/j.ijcard.2015.03.237. Epub 2015 Mar 18.</citation>
    <PMID>25841129</PMID>
  </reference>
  <reference>
    <citation>Musiałek P, Hopkins LN, Siddiqui AH. One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field. Postepy Kardiol Interwencyjnej. 2017;13(2):95-106. doi: 10.5114/pwki.2017.69012. Epub 2017 Jul 19. Review.</citation>
    <PMID>28798779</PMID>
  </reference>
  <reference>
    <citation>Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, Vega de Ceniga M, Windecker S, Zamorano JL. Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26. Review.</citation>
    <PMID>28851596</PMID>
  </reference>
  <reference>
    <citation>Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, Hamilton G, Kakisis J, Kakkos S, Lepidi S, Markus HS, McCabe DJ, Roy J, Sillesen H, van den Berg JC, Vermassen F, Esvs Guidelines Committee, Kolh P, Chakfe N, Hinchliffe RJ, Koncar I, Lindholt JS, Vega de Ceniga M, Verzini F, Esvs Guideline Reviewers, Archie J, Bellmunt S, Chaudhuri A, Koelemay M, Lindahl AK, Padberg F, Venermo M. Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Jan;55(1):3-81. doi: 10.1016/j.ejvs.2017.06.021. Epub 2017 Aug 26.</citation>
    <PMID>28851594</PMID>
  </reference>
  <reference>
    <citation>Morr S, Vakharia K, Fanous AA, Waqas M, Siddiqui AH. Utility of Intravascular Ultrasound During Carotid Angioplasty and Stenting with Proximal Protection. Cureus. 2019 Jun 18;11(6):e4935. doi: 10.7759/cureus.4935.</citation>
    <PMID>31431840</PMID>
  </reference>
  <reference>
    <citation>Chiocchi M, Morosetti D, Chiaravalloti A, Loreni G, Gandini R, Simonetti G. Intravascular ultrasound assisted carotid artery stenting: randomized controlled trial. Preliminary results on 60 patients. J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):248-252. doi: 10.2459/JCM.0b013e32835898f1.</citation>
    <PMID>23292649</PMID>
  </reference>
  <reference>
    <citation>Joan MM, Moya BG, Agustí FP, Vidal RG, Arjona YA, Alija MP, Paredero VM. Utility of intravascular ultrasound examination during carotid stenting. Ann Vasc Surg. 2009 Sep-Oct;23(5):606-11. doi: 10.1016/j.avsg.2008.09.010. Epub 2009 Jun 24.</citation>
    <PMID>19556101</PMID>
  </reference>
  <reference>
    <citation>Wehman JC, Holmes DR Jr, Ecker RD, Sauvageau E, Fahrbach J, Hanel RA, Hopkins LN. Intravascular ultrasound identification of intraluminal embolic plaque material during carotid angioplasty with stenting. Catheter Cardiovasc Interv. 2006 Dec;68(6):853-7.</citation>
    <PMID>17086527</PMID>
  </reference>
  <reference>
    <citation>Musiałek P, Roubin GS. Commentary: Double-Layer Carotid Stents: From the Clinical Need, through a Stent-in-Stent Strategy, to Effective Plaque Isolation… the Journey Toward Safe Carotid Revascularization Using the Endovascular Route. J Endovasc Ther. 2019 Aug;26(4):572-577. doi: 10.1177/1526602819861546.</citation>
    <PMID>31303133</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>June 7, 2020</last_update_submitted>
  <last_update_submitted_qc>June 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

